I'm curious to see the outcome if big pharma were

I'm curious to see the outcome if big pharma were to gain control of LL. Hopefully, its by one that doesn't have a large pipeline of drugs that would be hurt by the broad market applicable to LL. Otherwise, LL may be doomed to the shelf until the owner sees a big enough profit motive to let it out.